Literature DB >> 9242373

EGF induced SOS phosphorylation in PC12 cells involves P90 RSK-2.

E Douville1, J Downward.   

Abstract

SOS, the guanine nucleotide exchange factor for Ras, becomes phosphorylated on serine and threonine residues following stimulation of cells with growth factors. These phosphorylations may play a role in negative feedback of Ras stimulation and have been shown to be mediated in part by the MAP kinases Erk-1 and Erk-2. Here we show that in addition to MAP kinase, a major mitogen activated kinase for SOS is p90 Rsk-2, a downstream target of MAP kinase. p90 Rsk-2 phosphorylates SOS in an in gel assay and also in solution in vitro. The ability of p90 Rsk-2 to phosphorylate SOS increases greatly following EGF treatment of PC12 cells and is blocked by expression of N17 Ras or treatment with the MEK inhibitor PD98059. Phosphopeptide mapping revealed that the sites phosphorylated by p90 Rsk-2 in vitro were also phosphorylated in intact cells in response to EGF treatment. Several major sites of in vivo phosphorylation correlated with p90 Rsk-2 phosphorylation sites rather than MAP kinase sites. It is therefore likely that p90 Rsk-2 plays an important role in the down regulation of the Ras activation pathway through SOS.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9242373     DOI: 10.1038/sj.onc.1201214

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  61 in total

Review 1.  Mitogen-activated protein kinases: specific messages from ubiquitous messengers.

Authors:  H J Schaeffer; M J Weber
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

Review 2.  ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions.

Authors:  Philippe P Roux; John Blenis
Journal:  Microbiol Mol Biol Rev       Date:  2004-06       Impact factor: 11.056

3.  Grb2 is a negative modulator of the intrinsic Ras-GEF activity of hSos1.

Authors:  Natasha Zarich; José Luis Oliva; Natalia Martínez; Rocío Jorge; Alicia Ballester; Silvia Gutiérrez-Eisman; Susana García-Vargas; José M Rojas
Journal:  Mol Biol Cell       Date:  2006-06-07       Impact factor: 4.138

Review 4.  Tumor adaptation and resistance to RAF inhibitors.

Authors:  Piro Lito; Neal Rosen; David B Solit
Journal:  Nat Med       Date:  2013-11       Impact factor: 53.440

5.  Metabotropic glutamate receptor-initiated translocation of protein kinase p90rsk to polyribosomes: a possible factor regulating synaptic protein synthesis.

Authors:  F Angenstein; W T Greenough; I J Weiler
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

6.  Synthetic lethality screen identifies RPS6KA2 as modifier of epidermal growth factor receptor activity in pancreatic cancer.

Authors:  Nada Milosevic; Benjamin Kühnemuth; Leonie Mühlberg; Stefanie Ripka; Heidi Griesmann; Carolin Lölkes; Malte Buchholz; Daniela Aust; Christian Pilarsky; Sebastian Krug; Thomas Gress; Patrick Michl
Journal:  Neoplasia       Date:  2013-12       Impact factor: 5.715

7.  Regulation of the Small GTPase Ras and Its Relevance to Human Disease.

Authors:  Kayla R Kulhanek; Jeroen P Roose; Ignacio Rubio
Journal:  Methods Mol Biol       Date:  2021

8.  Integrated RAS signaling defined by parallel NMR detection of effectors and regulators.

Authors:  Matthew J Smith; Mitsuhiko Ikura
Journal:  Nat Chem Biol       Date:  2014-01-19       Impact factor: 15.040

9.  Relief of profound feedback inhibition of mitogenic signaling by RAF inhibitors attenuates their activity in BRAFV600E melanomas.

Authors:  Piro Lito; Christine A Pratilas; Eric W Joseph; Madhavi Tadi; Ensar Halilovic; Matthew Zubrowski; Alan Huang; Wai Lin Wong; Margaret K Callahan; Taha Merghoub; Jedd D Wolchok; Elisa de Stanchina; Sarat Chandarlapaty; Poulikos I Poulikakos; James A Fagin; Neal Rosen
Journal:  Cancer Cell       Date:  2012-11-13       Impact factor: 31.743

10.  Computational modelling of cancerous mutations in the EGFR/ERK signalling pathway.

Authors:  Richard J Orton; Michiel E Adriaens; Amelie Gormand; Oliver E Sturm; Walter Kolch; David R Gilbert
Journal:  BMC Syst Biol       Date:  2009-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.